Scott Hofer, DO
Sports Medicine · Osage Beach, MONPI 1285614354
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Elite Orthopedics, LLC at 54.0% of the total. Reporting peaked in 2023 at $1,391 and has fallen 77.4% since, to $315 in 2025.
Across 64 payments — averaging $49.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elite Orthopedics, LLC$2K
- Arthrex$462
- Pacira Therapeutics, Inc.$218
- Johnson & Johnson$180
- Vertex$125
- Sanofi-aventis U.S. LLC$123
- plus $346 from 14 others
What the payments were for
- Travel & lodging$1,16937%
- Food & beverage$1,33042%
- Education$66721%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elite Orthopedics, LLC | 8 | $1,711 |
| Arthrex | 4 | $462 |
| Pacira Therapeutics, Inc. | 13 | $218 |
| Johnson & Johnson(2 entities) | 7 | $180 |
| Vertex | 5 | $125 |
| Sanofi-aventis U.S. LLC | 8 | $123 |
| Pfizer | 3 | $51 |
| Radius Health, Inc. | 2 | $45 |
| Stryker | 1 | $30 |
| Endo Pharmaceuticals Inc. | 2 | $29 |
| Organogenesis Inc. | 1 | $26 |
| Ferring Pharmaceuticals Inc. | 2 | $26 |
| Solventum Corporation | 1 | $25 |
| AbbVie | 1 | $20 |
| DJO, LLC | 1 | $18 |
| Convatec Inc. | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $17 |
| Bioventus LLC | 1 | $16 |
| Amgen | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$3,166 in reported general payments places this provider in the 60th percentile of 127 sports medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $389 |
| Ibuprofen | 31 | $290 |
| Tramadol Hcl | 16 | $69 |
| Meloxicam | 25 | $67 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $51 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Osage Beach
- Kristin OliverColumbia$209K
- Steven DefrodaColumbia$101K
- Clayton NuelleColumbia$89K
- Justin DragerColumbia$78K
- Derrick KnapikSaint Louis$72K
- Shawn SahotaColumbia$69K
- James StannardColumbia$68K
- Joshua HamannColumbia$57K
- Jeffrey KlottColumbia$50K
- Scott KaarSt Louis$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.